Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Joseph Wheeler

TitleAdjunct Clinical Professor
InstitutionUniversity of Arkansas for Medical Sciences
DepartmentPediatrics, College of Medicine
DivisionPeds Infectious Diseases
Address ACH STURGIS
4301 W Markham St.
Mail Slot # 512-11
Little Rock AR 72205
Phone501-364-1416
vCardDownload vCard
    Other Positions
    TitleAssociate Professor
    InstitutionUniversity of Arkansas for Medical Sciences
    DepartmentCollege of Public Health


    Collapse Research Funds 
    Collapse principal investigator/co-principal investigator research activities
    D58HP05181     (KNIGHT, DANIEL)Jul 1, 2005 - Jun 30, 2013
    Health Resources & Services Administration
    Improving Care and Preventive Services for Vulnerable Populations
    Role: Co-Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions. Don't see publications published under other names? Login to add alternative names.
    List All   |   Timeline
    1. Cardenas VM, Breen PJ, Compadre CM, Delongchamp RR, Barone CP, Phillips MM, Wheeler JG. The smoking habits of the family influence the uptake of e-cigarettes in US children. Ann Epidemiol. 2015 Jan; 25(1):60-2. PMID: 25453726.
      View in: PubMed
    2. J Gary Wheeler, Susan Weinstein. Mosquito-borne infections: Diagnosis and treatment. AMS. 2013.
    3. J Gary Wheeler, Pamela Brown. Care Transitions: Focus on quality and accountability. AMS. 2011.
    4. Wheeler JG. Health Care Professionals as Coalition Members & Advocates. 2011.
    5. Nelson,K.M., Wheeler J, Juretschko,S. Molecular Diagnosis of Mycoplasma Pneumoniae for Pediatric Spinal Fluid. Journal of Investigative Medicine. 2010.
    6. Freeman,CL, Clement,K.C., Garcia, X, Wheeler J, Harik, NS. Lethal Rhabdomyolysis and Staphlococcus Aureus Sepsis in a Healthy Teenager. Journal of Investigative Medicine. 2010.
    7. Wheeler J, Compas,Carol. Building quallity improvement into Arkansas' trauma system. The Journal of the Arkansas Medical Society. 2009; 106(6):156,157.
    8. Brown,Pam, White,Elisa, Wheeler JG. Healthcare-associated infections. The Journal of the Arkansas Medical Society. 2009; 106(4):84-85.
    9. Wheeler J. Unintentional injuries. The Journal of the Arkansas Medical Society. 2009; 106(3):60-61.
    10. J Gary Wheeler, Stovall Stephanie. Neonatal Guideline Neonatal Human Immundefieciency Virus (HIV). 2009.
    11. Wheeler JG. Healthcare-associated infections. J. Ark Med Soc. 2009.
    12. Wheeler JG, Jacobs RF. Feigin & Cherry's Textbook of Pediatric Infectious Diseases. Lung Abscess. 2009; 30.
    13. Wheeler JG, Jacobs RF. Feigin & Cherry's Textbook of Pediatric Infectious Diseases. Pleural Effusions and Empyema. 2009; 29.
    14. Wheeler JG. Kids are heading back to school-that means it's vaccine time!. 2008.
    15. Wheeler JG, Pulley L, Felix HC, Bursac Z, Siddiqui NJ, Stewart MK, Mays GP, Gauss CH. Impact of a smoke-free hospital campus policy on employee and consumer behavior. Public Health Rep. 2007 Nov-Dec; 122(6):744-52. PMID: 18051667.
      View in: PubMed
    16. Sheffer, Christine, Wheeler J. Legislation of Smoke-Free Medical Facilities. A Survey of CEOs. 2007.
    17. Wheeler J, Sheffner,Christine. Effectiveness of Statewide Implementation of Intensive Treatment Services. APHA. 2007.
    18. Hageman JC, Uyeki TM, Francis JS, Jernigan DB, Wheeler JG, Bridges CB, Barenkamp SJ, Sievert DM, Srinivasan A, Doherty MC, McDougal LK, Killgore GE, Lopatin UA, Coffman R, MacDonald JK, McAllister SK, Fosheim GE, Patel JB, McDonald LC. Severe community-acquired pneumonia due to Staphylococcus aureus, 2003-04 influenza season. Emerg Infect Dis. 2006; 12(6):894 - 899.
    19. Wheeler JG, Pulley L, Felix HC, Bursac Z, Siddiqui N, Stewart MK, Mays G, Gauss H, Richter J. Employee and Consumer response to a Smoke-free Hospital campus policy. APHA. 2006.
    20. Wheeler JG, Pulley L, Felix HC, Bursac Z, Siddiqui N, Stewart MK, Mays G. Employee and consumer response to a smoke-free hospital campus policy. American Public Health Association. 2006.
    21. Sheffer CE, Wheeler JG, Raczynski JM, Wayne JB. Evaluation of a legislated smokefree policy in Arkansas. 2006.
    22. Nomura I, Abe J, Noma S, Gao B, Wheeler JG, Leung DYM. Adrenomedullin is highly expressed in blood monocytes associated with acute Kawasaki disease: a microarray gene expression study. Pediatric Research. 2005; 57(1):49-55.
    23. Carroll PA, Kahn RF, Vannatta PM, O'Sullivan PS, Wheeler JG. "Using a Video Problem-based Learning on Adolescent Obesity: A Comparison of Dietetic Interns and Medical Students". Food & Nutrition Conference. 2005.
    24. Thrush CR, O'Sullivan PS, Wheeler JG, Nesmith JD, Blaszak RT, Kamin C. Using Video Problem Based Learning to Improve Student Attitudes and Beliefs about Pediatric Obesity. AAMC Annual Meeting. 2005.
    25. Wheeler JG, Young K, Norman-Drinkwater M, Goel R, Simpson P, Ilyas M. Relationship of blood pressure change to weight change in overweight children. Society for Pediatric Research/PAS. 2005.
    26. Davis AB, Wheeler JG, Pulley L, Oldani J. Adolescent Attitudes toward Second-hand smoke. National Conference on Tobacco or Health. 2005.
    27. Buck RH, Thomas DL, Winship TR, Cordle CT, Kuchan MJ, Baggs GE, Schaller JP, Wheeler JG. Effect of dietary ribonucleotides of infant immune status. Part 2: immune cell development. Pediatric Research. 2004; 56:891-900.
    28. Schaller JP, Kuchan M, Thomas DL, Cordle CT, Winship TR, Buck RH, Baggs GE, Wheeler JG. Effect of dietary ribonucleotides on infant immune status. Part 1: humoral responses. Pediatric Research. 2004; 56:883-890.
    29. Buck RH, Thomas DL, Winship TR, Cordle CT, Kuchan MJ, Baggs GE, Schaller JP, Wheeler JG. Effect of dietary ribonucleotides on infant immune status. Part 2: Immune cell development. Pediatr Res. 2004; 56(6):891 - 900.
    30. Schaller JP, Kuchan MJ, Thomas DL, Cordle CT, Winship TR, Buck RH, Baggs GE, Wheeler JG. Effect of dietary ribonucleotides on infant immune status. Part 1: Humoral responses. Pediatr Res. 2004; 56(6):883 - 890.
    31. Roberts GM, Wheeler JG, Tucker NC, Hackler C, Young K, Maples HD, Darville T. Non-adherence with pediatric HIV therapy as medical neglect?. Pediatrics. 2004; 114:e1-e8.
    32. Vargas PA, Simpson P, Wheeler JG, Goel R, Field C, Tilford M, Jones SM. Characteristics of Children with Asthma in a Head Start Program. J Allerg and Clin Immunol. 2004; 114(3):499-504.
    33. Carroll PA, Hakkak R, Kahn R, Vannatta PM, Wheeler JG. Nutritional curricula development for first-year medical students in an interdisciplinary training with dietetic interns. 2004; A-36.
    34. Wheeler JG, Tran TC, North P, Beavers-May T, Schutze GE, Snow SL. Barriers to public health management of a pertussis outbreak in Arkansas. Arch Pediatr Adolesc Med. 2004 Feb; 158(2):146-52. PMID: 14757606.
      View in: PubMed
    35. Wheeler JG, Kahn R, Garner C, Vannatta P. Obesity in Arkansas; from contemplation to Action. J Ark Med Soc. 2004; 100:268-272.
    36. Hakkak R, Kahn RF, Vannatta PM, O'Sullivan PS, Wheeler JG, Carroll PA. How are 3rd year medical students using a booklet to guide cardiovascular risk and nutrition assessments in practice?. 2004; A1212.
    37. Young KL, Wheeler JG, Peck D, Goel R. Incidence of severe obesity in a tertiary pediatric weight management clinic. North American Association for the study of obesity (NAASO). 2004.
    38. Hakkak R, Kahn RF, Vannatta PM, O'Sullivan PS, Wheeler JG, Carroll PA. Development of cardiovascular disease and nutrition assessment booklet for 3rd year medical students in a family practice clerkship. 2004; A1212.
    39. Howard V, Myers LA, Williams DA, Wheeler JG, Turner EV, Cunningham JM, Branstetter Y, Conley ME. Stem cell transplants for patients with X-linked Agammmaglobulinemia. Clinical Immunology. 2003; 107:98-102.
    40. Dawson L, Wheeler JG, Malcolm M. Initiating change: Tobacco free hospitals of Arkansas. National Conference on Tobacco or Health. 2003.
    41. Roberts GM, Tucker NC, Wheeler JG, Simpson PM, Darville T. Intervention strategies for HIV-Infected children non-compliant with antiretroviral therapy-noncompliance considered as medical neglect. 2003; S266.
    42. Jones SM, Wheeler JG, Feild CR, Simpson PA, Vargas PA. Aeroallergen sensitivity and environmental tobacco exposure among headstart children with symptoms of asthma. Pediatric Academic Society. 2003.
    43. Leung DY, Meissner HC, Shulman ST, Mason WH, Gerber MA, Glode MP, Myones BL, Wheeler JG, Ruthazer R, Schlievert PM. Prevalence of superantigen-secreting bacteria in patients with Kawasaki disease. J Pediatr. 2002; 140(6):742 - 746.
    44. Scurlock AM, Vargas PA, Field CR, Simpson PM, Wheeler JG, Barrett KW, Flick EL, Jones SM. Assessment of Pediatric asthma awareness among headstart staff. Southern Society for Pediatric Research. 2002; 97A.
    45. Jones SM, Wheeler JG, Field CR, Simpson PM, Barrett KW, Flick ML, Vargas PA. Prevalence of aerolallergen sensitivity and passive tobacco smoke exposure among head start children with symptoms of asthma. Southern Society for Pediatric Research. 2002; 137A.
    46. Vargas PA, Jones CA, Wheeler JG, Et al. Asthma Screening in Headstart Children. International Conference of the American Thoracic Society. 2002.
    47. Robbins JM, Tilford JM, Gillaspy SR, Lensing SY, Jacobs RF, Wheeler JG. Parental emotional and time costs predict compliance respiratory syncytial virus prophylaxis. Ambulatory Pediatrics. 2002; 2:444-448.
    48. Jones SM, Wheeler JG, Feild CR, Simpson PA, Barrett KW, Vargas PA. Prevalence of Aeroallergen Sensitivity and Passive Tobacco Smoke Exposure Among Headstart Children with Symptoms of Asthma. International Conference of the American Thoracic Society. 2002.
    49. Vargas PA, Wheeler JG, Feild CR, Simpson PM, Barrett KW, Tilford JM, Jones SM. Sustainable Asthma Management Model for Headstart children. CDC National Asthma Conference. 2002.
    50. Vargas PA, Wheeler JG, Field CR, Simpson PA, Barrett KW, Tilford JM, Jones SM. Developing a sustainable asthma program headstart children. International Conference of the American Thoracic Society. 2002.
    51. Aitken M, Wheeler JG, Rowlands LA. Pediatric advocacy: more lessons. Arch Pediatr Adolesc Med. 2001; 155(12):1390 - .
    52. Meissner HC, Schlievert PM, Shulman ST, Mason W, Wheeler JG, Myones BL, Glode MP, Ruthazer Ger MA, Leung DM. A multicenter, controlled, blinded study to evaluate the role of bacterial superantigens in patients with Kawasaki's syndrome. Society for Pediatric Research. 2001.
    53. Wheeler JG, Fair M, Simpson PM, Rowlands LA, Aitken ME, Jacobs RF. Impact of Parent-focused Educational Videotapes on Pediatric Antibiotic Use. Pediatrics. 2001; 108:591-596.
    54. Buck RH, Thomas DL, Winship TR, Cordle CT, Schaller JP, Kuchan MJ, Baggs GE, Wheeler JG. Dietary Nucleotides enhance immune cell maturation in infants. North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition. 2001.
    55. Wheeler JG. New management for the prevention and treatment of influenza. Seminars in Pediatric Infectious Diseases. 2001; 12:235-245.
    56. Smith LN, Wheeler JG, Shaw JL, Simpson DD, Robbins JM. Physician compliance with voluntary and mandatory vanomycin guidelines in a children's hospital. 2001; 106A.
    57. Schaller JP, Wheeler JG, Thomas DL, Cordle CT, Winship TR, Buck RH, Faden H, Granoff DM, Jacobs RF, Kuchan MJ. Vaccine response in infants fed formula containing nucleotides. North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition. 2001.
    58. Wheeler JG, Fair M, Rowlands LA, Simpson PM, Jacobs RF. Impact of Parent-focused Educational Videotapes on Pediatric Antibiotic Use. 2000; 234A.
    59. Murdoch M, Simpson D, Robbins JM, Wheeler JG. Vancomycin restriction policy. Southern Society for Pediatric Research. 2000.
    60. Robbins JM, Tilford JM, Gillaspy SR, Simpson DD, Wheeler JG, Shaw JL, Jacobs RF. Emotional and time costs of respiratory syncytial virus prophylaxis: comparing palivizumab to RSV-IG. 2000; 221A.
    61. Burks AW, Jones SM, Wheeler JG, Sampson HA. Immunology and Allergy Clinics of North America. Anaphylaxis and food hypersensitivity in: Food allergy: current knowledge and future directions. 1999.
    62. Robbins JM, Tilford JM, Gillaspy SR, Thomas MD, Lensing SY, Wheeler JG. Baby and parental reactions to RSV-IG administration. 1999; 159A.
    63. Cairo MS, Agosti J, Ellis R, Laver JJ, Puppala B, DeLemos R, Givner L, Nesin M, Wheeler JG, Seth T, Van d, Fanaroff A. A randomized, double-blind, placebo-controlled trial of prophylactic recombinant human granulocyte-macrophage colony-stimulating factor to reduce nosocomial infections in very low birth weight neonates. J Pediatr. 1999; 134(1):64 - 70.
    64. Russ J, Sherrill A, Jones S, Burks AW, Wheeler JG. Impact of IVIG shortage on patient illness. Southern Society for Pediatric Research. 1999; 107A.
    65. Kearns GL, Wheeler JG, Rieder MJ, Reid J. Serum sickness-like reaction to cefaclor: lack of in vitro cross-reactivity with loracarbef. Clin Pharmacol Ther. 1998; 63(6):686 - 693.
    66. Spector SL, Bernstein IL, Li TJ, Wheeler JG. Parameters for the diagnosis and Management of Sinusitis. J Allerg and Clin Immunol. 1998; 102(2):S107-S144.
    67. Wheeler JG, Jacobs RF. Textbook of Pediatric Infectious Diseases. Lung Abscess. 1998.
    68. Hatley TK, Wheeler JG, Burks AW, Jones SM. Clinical spectrum of disease in patients with Digeorge anomaly. Southern Society for Pediatric Research. 1998; 28A.
    69. Wheeler JG, Jacobs RF. Textbook of Pediatric Infectious Diseases. Pleural Effusion and Empyema. 1998.
    70. Robbins JM, Wheeler JG, Gillaspy SR, Tilford JM, Cheadle MG, Clayton JE. Follow-up of infants treated with respiratory syncytial virus immune globulin. Southern Society for Pediatric Research. 1998; 4A.
    71. Gill MA, Wheeler JG, James JM, Sawyer JR, Gibson JG, Schutze GE, Rae J, Curnutte JT. Chronic granulomatous disease unmasked as contiguous Xp21 deletion syndrome. 1997; 48A.
    72. James JM, Robbins JM, Gillaspy SR, Kellogg KW, Fawcett DD, Burks AW, Jones SM, Magee J, Menendez A, Morris M, Schellhase D, Simmons L, Warren R, Wheeler JG. Patients referrals to a multispecialty asthma clinic. J Asthma. 1997; 34:387-394.
    73. Gill MA, Wheeler JG, James JM, Sawyer JR, Gibson JG, Schutze GE, Rae J, Curnutte JT. Chronic granulomatous disease unmasked as contiguous Xp21 deletion syndrome. 1997; 1931.
    74. Robbins JM, Tilford JM, Jacobs RF, Gillaspy SR, Schutze GE. A number needed to treat analysis of RSV-IG for the prevention of hospitalization. Society for Pediatric Research. 1997.
    75. Shirrell MA, Jones SM, James JM, Wheeler JG, Schellhase DE, Saylors RL, Schiff RI, Burks AW. Fatal lymphoprolifeative disorder five years after bone marrow transplant for sever combined immunodeficiency disease. 1997; 718.
    76. White CJ, Stinson D, Staelhe B, Et al. Measles, Mumps, Rubella, and Varicella combination vaccine: safety and immuogenicity alone and in combination with other vaccines given to children. Clin Infect Dis. 1997; 24:925-31.
    77. Gelfand E, Burckhart G, Wheeler JG, Et al. Critical Issues in the Therapeutic Use of IVIG. National Jewish Medical and Research Center. 1996.
    78. Winklestein J, Lederman HM, Wheeler JG. Immunodeficiency-office presentation and workup. AAP Pediatric Update. 1996; 17(3):Audiotape series.
    79. Wheeler JG, Burks, AW. What to do when you suspect antibiotic hypersensitivity. J Resp Dis. 1996; 17:103-114.
    80. Abramson JS, Wheeler JG, Quie PG. Immunologic disorders in infants and children. The Polymorphonuclear Leukocyte. 1996; 5.
    81. Cairo MS, Seth T, Fanaroff A, Puppala B, DeLemos R, Givner L, Laver J, Nesin M, Wheeler JG, Agosti J. Double blinded randomized placebo controlled pilot study of RhGM-CSF in low birth weight neonates. Preliminary results demonstrate a significant reduction in nosocomial infections with RhuGM-CSF. SPR. 1996.
    82. Wheeler JG, Sikes JD, Kearns GL. TCR-Beta chain expression in drug hypersensitivity. Clinical Immunology Society. 1996.
    83. Helm RM, Wheeler JG, Burks AW, Badger TM. Imunologic analysis of rats following the administration of ethanol in a total enteral nutrition (TEN) system. SSPR. 1995; 67A.
    84. Maxson S, Shema S, Schutze GE, Darville T, Wheeler JG, Jacobs RF. Acute hematogenous osteomyelitis: treatment and clinical outcome. SSPR. 1995; 37A.
    85. Wheeler JG, Kearns GL. A clinical guide to antibiotic hypersensitivity. Antimicrobials and infectious diseases newsletter. 1995; 14:45-50.
    86. Sawyer JR, Swanson CM, Wheeler JG, Cuniff C. Chromosome instability in ICF syndrome: formation of micronuclei from multibranched chromosomes 1 demostrated by fluorescence in situ hybridization. Amer J Med Genet. 1995; 56:203-209.
    87. Pascual C, Crespo JF, Quiralte J, Lopez C, Wheeler JG, Martin-Estaban M. In vitro detection of specific IgE antibodies to erythromycin. J Allergy Clin Immunol. 1995; 95:668-671.
    88. Wheeler JG, Sikes JD. ICAM-1 is not a binding site for influenza A virus. SSPR. 1995; 25A.
    89. Hogan AD, James JM, Wheeler JG, Burks AW, Graham ML, Harville T. Th2-Type response in Omenn's syndrome (OS) resolved after bone marrow transplantation (BMT). AAAI. 1995.
    90. Abramson JS, Wheeler JG. Virus-induced neutrophil dysfunction: role in the pathogenesis of bacterial infections. Pediatr Infect Dis J. 1994; 13(7):643 - 652.
    91. Wheeler JG, Burks AW, Badger TM. Cellular and humoral responses to Diptheria/Tetanus vaccination in neonatal pigs. 1994; 17A.
    92. Wheeler JG, Jacobs RF. Clinical use of ribavirin and ganciclovir. Res Staff Physician. 1994; 40:47-55.
    93. Hickerson SL, Kirby RS, Wheeler JG, Schutze GS. Epiglottitis: an 8 year case review. 1994; 732A.
    94. Jones OY, Wheeler JG. The levels of S100B-protein in T-suppressor lymphocytes from epileptic patients. American Academy of Pediatrics. 1994.
    95. Schutze GE, Flick EL, Wheeler JG, Kirby RS. Risk factors for development of Salmonellosis in children less than four years of age. 1994.
    96. Wheeler JG, Jacobs RF. Practical approach to the use of acyclovir. Res Staff Physician. 1994; 40:36-46.
    97. Kearns GL, Wheeler JG. Bioactivation of Cefaclor by CYP3A modulates its cytotoxicity in man. American Academy of Allergy and Immunology. 1994.
    98. Wheeler JG, Kearns GL, Sikes JD, Childress SH. Lymphocyte cytotoxicity induced by cefaclor: assessment by flow cytometry. 1994.
    99. Wheeler JG, Wofford J, Turner RB. Historical cohort evaluation of ribavirin efficacy in respiratory syncytial virus infection. Pediatr Infect Dis J. 1993; 12(3):209 - 213.
    100. Abramson JS, Wheeler JG. The Neutrophil. Oxford University Press. 1993.
    101. Wheeler JG, Childress SC, Kearns GL. Cefaclor serum sickness: In vitro identification using microsome cytotoxicity and flow cytometry. 1993; A482.
    102. Kearns GL, Wheeler JG. Cefaclor hypersensitivity: a metabolic basis. 1993; 240.
    103. Wheeler JG, Abramson JS. The Neutrophil. Microbial and Pharmacological induction of neutrophil dysfunction. 1993.
    104. Wheeler JG, Givner LB. Therapeutic use of recombinant human granulocyte-macrophage colony-stimulating factor in neonatal rats with type III group B streptococcal sepsis. J Infect Dis. 1992; 165(5):938 - 941.
    105. Wheeler JG, Wofford JL, Turner RB. Two center comparison of respiratory syncytial virus infected patients treated with or without Ribavirin. 1992; 862A.
    106. Wheeler JG, Childress SH, Kearns GL. Flow cytometric method of measuring in vitro drug induced lymphocyte cytotoxicity. 1992; 804A.
    107. Kearns GL, Wheeler JG, Childress SH. A metabolic basis for cefaclor hypersensitivity. 1992; 804A.
    108. Huffine ME, Sikes J, Wheeler JG. Effect of granulocyte-colony stimulating factor (GM-CSF) on in vitro neutrophil (PMN) diapedesis. 1992; 785A.
    109. Abramson JS, Wagner MP, Ralston EP, Wei Y, Wheeler JG. The ability of polymorphonuclear leukocyte priming agents to overcome influenza A virus-induced cell dysfunction. J Leukoc Biol. 1991; 50(2):160 - 166.
    110. Wheeler JG, Abramson JS, Quie P. Immunologic disorders in infants and children. The Polymorphonuclear phagocytic system. 1991.
    111. Wheeler JG, Cunningham DC, Abramson JS. Granulocyte/macrophage colony stimulating factor (CM-CSF) in chinchilla model of influenza A virus- (IAV) induced pneumococcal superinfection. 1991; 188A.
    112. Wheeler JG, Givner LB. The effect and mechanism of action of franulocyte macrophage colony-stimulating factor (GM-CSF) on mortality in group B streptococcus (III-GBS) septic neonatal rats. 1991; 289A.
    113. Stone BD, Wheeler JG. Disseminated cryptococcal infection in a patient with hyperimmunoglobulinemia E syndrome. J Pediatr. 1990; 117(1 Pt 1):92 - 95.
    114. Wheeler JG, Winkler LS, Seeds M, Bass D, Abramson JS. Influenza A virus alters structural and biochemical functions of the neutrophil cytoskeleton. J Leukoc Biol. 1990; 47(4):332 - 343.
    115. Wheeler JG, Givner LB. Recombinant granulocyte-macrophage colony-stimulating factor reduces mortality in neonatal rats infected with III-Group B streptococcus. 1990; A1869.
    116. Abramson JS, Ralston B, Wagner MP, Wheeler JG. Potential therapies to overcome influenza A virus (IAV) induced alterations in polymorphonuclear leukocytes G-protein function. 1990; 164A.
    117. Wheeler JG, Abramson JS, Quie P. Natural Immunity. Polymorphonuclear Leukocytes. 1989.
    118. Wheeler JG, Abramson JS. Influenza A virus (IAV) alters actin distribution in polymorphonuclear leukocytes (PMNL). 1988; 270.
    119. Wofford ML, Wheeler JG, Abramson JS. Predominance of gram positive infections in pediatric acute lymphocytic leukemia (ALL) during induction and first remission. 1988; 349A.
    120. Abramson JS, Winkler LS, Wheeler JG. Alterations in phosphorylation of polymorphonuclear (PMNL) cytoskeleton proteins induced by influenza virus. 1988; 350A.
    121. Wheeler JG, Chauvenet AR, Johnson CA, Block SM, Dillard R, Abramson JS. Buffy coat transfusions in neonates with sepsis and neutrophil storage pool depletion. Pediatrics. 1987; 79(3):422 - 425.
    122. Wheeler JG, Cassidy LF, Caldwell SE, Bass DA, Abramson JS. Influenza A virus (IAV) may induce cytoskeleton dysfunction in polymorphonuclear leukocytes (PMNL) depressing protein phosphorylation. 1987; 320A.
    123. Abramson JS, Wheeler JG, Parce JW, Rowe MJ, Lyles DS, Seeds M, Bass DA. Suppression of endocytosis in neutrophils by influenza A virus in vitro. J Infect Dis. 1986; 154(3):456 - 463.
    124. Wheeler JG, Abramson JS, Johnson CA, Chauvenet AR, Swingle HM, Block RG, Dillard RG. Preliminary findings of a randomized study of buffy coat transfusions in septic neutropenic neonates. 1986; 403A.
    125. Wheeler JG, Abramson JS, Bass DA. Effects of influenza A virus (AV) on polymorphonuclear leukocyte (PMNL) calcium regulation and cytoskeletal function. Program Abs-Intersci conf. 1986; 186.
    126. Wheeler JG, Boyle RJ, Abramson JS. Intralipid infusion in neonates: effects on polymorphonuclear leukocyte function. J Pediatr Gastroenterol Nutr. 1985; 4(3):453 - 456.
    127. Abramson JS, Wheeler JG, Parce JW, Et al. Effect of influenza A on neutrophil endocytosis. 1985; 393A.
    128. Wheeler JG, Chauvenet AR, Johnson CA, Dillard R, Block SM, Boyle R, Abramson JS. Neutrophil storage pool depletion in septic, neutropenic neonates. Pediatr Infect Dis. 1984; 3(5):407 - 409.
    129. Wheeler JG, Abramson JS, Ekstrand K. Function of irradiated polymorphonuclear leukocytes obtained by buffy-coat centrifugation. Transfusion. 1984; 24(3):238 - 239.
    130. Wheeler JG, Abramson JS, Boyle RJ, Chauvenet AR, Johnson CA, Block SM, Dillard RJ. Bone marrow examinations in septic neutropenic neonates. 1984; 355A.
    131. Wheeler JG, Weesner KM. Staphylococcus aureus endocarditis and pericarditis in an infant with a central venous catheter. Clin Pediatr (Phila). 1984; 23(1):46 - 47.
    132. Wheeler JG, Boyle RJ, Abramson JS. In vivo and in vitro effects of intralipid (IL) on neonatal polymorphonuclear leukocytes (PMNL). 1983; 204A.
    133. Wheeler JG, Boyle R, Abramson J. Candida tropicalis pyelonephritis successfully treated with 5-fluoroctosine and surgery. J Pediatr. 1983; 102:627-629.
    Wheeler's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description